By CapitalSnitch Research Desk · updated Oct 11, 2026 · data from SEC filings and official Congress disclosures
Over the past year there were no insider purchases at BIO-TECHNE Corp. One insider sold roughly $437,000 instead.
Keep in mind most insider selling is routine — stock-based pay has to be converted to cash at some point.
TECH also shows up in congressional disclosures: 14 reported trades from three lawmakers in two years. Zooming out by quarter: No open-market insider buying or selling in the last full quarter. Insiders bought in 0 of the last 7 full quarters. On the institutional side, 596 funds reported holding TECH at the end of Q2 2026, and more funds sold than bought.
Are insiders buying or selling TECH stock?
In the last 12 months BIO-TECHNE Corp insiders made open-market purchases worth about $0 and sales worth about $437,000. Data comes from SEC Form 4 filings, updated every 30 minutes on CapitalSnitch.
When was the last insider trade in TECH?
The most recent open-market insider trade in TECH was filed on 2026-05-12.
How many institutions own TECH?
596 investment managers reported holding TECH in SEC Form 13F filings for Q2 2026.
Has any member of Congress traded TECH?
Yes. Members of Congress reported 14 trades in TECH over the past two years. The full list is free on CapitalSnitch.
Free weekly email: the week's biggest insider buys and Congress trades, every Monday. No spam, one-click unsubscribe.
Public-record data for research and education, not investment advice. Insider sales are often pre-planned (10b5-1).
Congress data: Data derived from public disclosures filed under the Ethics in Government Act and the STOCK Act, republished free for public transparency and news reporting. Disclosures may lag the trade by 45 days or more and show amounts only as ranges. This data may not be used for credit rating, loan underwriting, solicitation of money (political, charitable or other), direct-mail or commercial targeting (5 U.S.C. 13107).